|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
University Hospital, Bonn University Hospital Mannheim |
| Information provided by: | University Hospital, Bonn |
| ClinicalTrials.gov Identifier: | NCT00373438 |
Purpose
Diaphragmatic hernia detected in fetal life carries a high risk for postnatal lung failure due to lung underdevelopment. In these cases, extracorporeal membrane oxygenation (ECMO) can be used as a life-saving intensive care means to enable survival of severely affected infants.
Clinical experience from prospective controlled non-randomized case series with fetoscopic tracheal balloon occlusion has seen improved survival rates in contrast to untreated controls.
Therefore, the purpose of this randomized clinical trial in a less severe subgroup of patients is whether by fetoscopic tracheal occlusion in fetal life, the intensity of postnatal intensive care therapy might be reduced. Primary outcome measure is the need for postnatal ECMO therapy.
| Condition | Intervention |
|
Diaphragmatic Hernia |
Procedure: Fetoscopic tracheal balloon occlusion |
| MedlinePlus related topics: | Hernia |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Open Label, Active Control, Factorial Assignment, Safety/Efficacy Study |
| Official Title: | Randomized Clinical Trial for the Assessment of the Life-Saving Potential of Fetoscopic Tracheal Balloon Occlusion in Fetuses With Severe Congenital Diaphragmatic Hernia - EUROTRIAL II |
| Estimated Enrollment: | 98 |
| Study Start Date: | October 2008 |
| Estimated Study Completion Date: | June 2013 |
| Estimated Primary Completion Date: | October 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
| A: No Intervention |
Procedure: Fetoscopic tracheal balloon occlusion
Maternal local anesthesia, percutaneous ultrasound-guided fetal analgo-sedation and relaxation, percutaneous ultrasound-guided access into amniotic cavity with trocar, fetoscopic tracheal ballon occlusion, removal of fetoscope and trocar, maternal abdominal closure, skin-to-skin time 30 minutes
|
|
B: Experimental
Fetoscopic tracheal occlusion
|
Procedure: Fetoscopic tracheal balloon occlusion
Maternal local anesthesia, percutaneous ultrasound-guided fetal analgo-sedation and relaxation, percutaneous ultrasound-guided access into amniotic cavity with trocar, fetoscopic tracheal ballon occlusion, removal of fetoscope and trocar, maternal abdominal closure, skin-to-skin time 30 minutes
|
Eligibility
| Ages Eligible for Study: | 18 Years to 50 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations| Contact: Thomas Kohl, MD | -49-228-2871-5942 | thomas.kohl@ukb.uni-bonn.de |
| Contact: Thomas Schaible, MD | -49-160-550-1023 | t.schaible@t-online.de |
| Germany | |||||
| German Center for Fetal Surgery & Minimally-Invasive Therapy | Not yet recruiting | ||||
| Bonn, Germany, 53105 | |||||
| Contact: Thomas Kohl, MD -49-228-2871-5942 thomas.kohl@ukb.uni-bonn.de | |||||
| Contact: Thomas Schaible, MD -49-160-550-1023 t.schaible@t-online.de | |||||
| University Hospital, Bonn |
| University Hospital Mannheim |
| Principal Investigator: | Thomas Kohl, MD | German Center for Fetal Surgery & Minimally-Invasive Therapy, University of Bonn, Germany |
| Principal Investigator: | Thomas Schaible, MD | Neonatal Intensive Care Unit (ECMO center), University of Mannheim, Germany |
More Information
Homepage of the German Center for Fetal Surgery & Minimally-Invasive Therapy, University of Bonn, Germany 
  |
| Responsible Party: | German Center for Fetal Surgery & Minimally-Invasive Therapy ( Thomas Kohl MD ) |
| Study ID Numbers: | DH-EUROTRIAL II - 135/06, 135/06 |
| First Received: | September 6, 2006 |
| Last Updated: | August 22, 2008 |
| ClinicalTrials.gov Identifier: | NCT00373438 |
| Health Authority: | Germany: Ethics Commission |
|
|
|